The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective

@inproceedings{Leelarathna2018TheVO,
  title={The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective},
  author={L Leelarathna and Donna M Ashley and Carrie Fidler and Witesh Parekh},
  booktitle={Therapeutic advances in endocrinology and metabolism},
  year={2018}
}
Background Fast-acting insulin aspart is a new formulation of the rapid-acting insulin analogue insulin aspart and represents an advancement over current rapid-acting insulin analogues in terms of onset of action and postprandial glucose control. The objective of the current analysis was to demonstrate the cost impact of prescribing fast-acting insulin… CONTINUE READING